John Kinnard Ferguson MacLean

Title: John Kinnard Ferguson MacLean: Innovator in Heterocyclic Derivatives

Introduction

John Kinnard Ferguson MacLean is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on heterocyclic derivatives. His innovative approach has the potential to impact the treatment of various disorders.

Latest Patents

MacLean holds a patent for heterocyclic derivatives, which relates to a compound of formula (I) as defined in the specification. This invention also encompasses pharmaceutically acceptable salts or solvates of the compound. The patent further details pharmaceutical compositions that include these heterocyclic derivatives and their therapeutic applications, particularly in treating disorders mediated by nicotinic acetylcholine receptors, such as schizophrenia and Alzheimer's disease. He has 1 patent to his name.

Career Highlights

MacLean is associated with Merck Sharp & Dohme B.V., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Throughout his career, MacLean has collaborated with esteemed colleagues, including Paul David Ratcliffe and Thomas Russell Clarkson. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

John Kinnard Ferguson MacLean is a distinguished inventor whose work on heterocyclic derivatives holds promise for the treatment of significant medical conditions. His contributions to the pharmaceutical field exemplify the impact of innovation in healthcare.